<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1770">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 10, 2022</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00453544</url>
  </required_header>
  <id_info>
    <org_study_id>IA0110</org_study_id>
    <secondary_id>1R01AG028827</secondary_id>
    <nct_id>NCT00453544</nct_id>
  </id_info>
  <brief_title>Enhancing Consent for Alzheimer's Research</brief_title>
  <acronym>BWP-AD</acronym>
  <official_title>Enhancing Consent for Alzheimer's Research</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, San Diego</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute on Aging (NIA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of California, San Diego</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the efficacy of an enhanced consent procedure for&#xD;
      patients with mild-to-moderate Alzheimer disease, and to identify factors and patient&#xD;
      characteristics that predict the degree to which enhanced consent is more beneficial than&#xD;
      routine consent procedures.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Alzheimer disease can impair the capacity of patients to give informed consent for research&#xD;
      participation. Studies of informed consent involving other patient populations suggest better&#xD;
      understanding of consent-relevant information may be achieved through modifications in the&#xD;
      consent delivery process, including incorporation of multimedia learning tools into the&#xD;
      consent discussion.&#xD;
&#xD;
      In the present study, participants with Alzheimer disease and age-comparable healthy&#xD;
      participants will be randomly assigned to review a hypothetical research protocol via routine&#xD;
      or enhanced consent procedures. Participants will also complete standard cognitive and other&#xD;
      rating scales so that we can characterize the sample, as well as evaluate the degree to which&#xD;
      specific characteristics may be associated with need for enhanced consent procedures.&#xD;
      Advances in the methods to optimize the informed consent process should enable future&#xD;
      research participants to make more fully informed decisions.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2006</start_date>
  <completion_date type="Actual">September 2012</completion_date>
  <primary_completion_date type="Actual">September 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Level of Understanding</measure>
    <time_frame>Within session</time_frame>
    <description>Modified version of the MacCAT-CR Understanding subscale</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Appreciation</measure>
    <time_frame>Immediate</time_frame>
    <description>MacCAT-CR Appreciation subscale</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Reasoning</measure>
    <time_frame>Within session</time_frame>
    <description>MacCAT-CR Reasoning subscale</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Expression of a Choice regarding hypothetical protocol</measure>
    <time_frame>Within session</time_frame>
    <description>MacCAT-CR</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Level of Satisfaction with consent process</measure>
    <time_frame>Within session</time_frame>
    <description>Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Expressed willingness to participate in the hypothetical protocol</measure>
    <time_frame>Within session</time_frame>
    <description>Question/interview</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">252</enrollment>
  <condition>Alzheimer Disease</condition>
  <arm_group>
    <arm_group_label>Enhanced consent - A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The intervention was an enhanced consent process, including a multimedia aid for a moderate risk hypothetical protocol</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Enhanced consent - B</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The intervention was an enhanced consent process, including multimedia aide for a higher risk hypothetical protocol</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Routine consent - A</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>This was a comparison condition - a routine consent process, including a printed consent document, for a moderate risk hypothetical protocol</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Routine consent - B</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>This was a comparison condition - a routine consent process, including a printed consent document, for a higher risk hypothetical protocol</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Enhanced Consent Procedure</intervention_name>
    <description>This is a procedure involving use of multimedia materials, as well as standard review with research staff, to see if the research consent procedure can be improved</description>
    <arm_group_label>Enhanced consent - A</arm_group_label>
    <arm_group_label>Enhanced consent - B</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Routine Consent Procedure</intervention_name>
    <description>This is a procedure designed to be in accord with standard research consent practices (and lacks multimedia aids)</description>
    <arm_group_label>Routine consent - A</arm_group_label>
    <arm_group_label>Routine consent - B</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Clinical diagnosis of mild to moderate possible or probable AD or demographically&#xD;
             comparable healthy comparison subjects&#xD;
&#xD;
          -  Fluency in English&#xD;
&#xD;
          -  50 yrs and older&#xD;
&#xD;
          -  Informed written consent (or written assent with consent from legally authorized&#xD;
             representative)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Diagnosis of Lewy Body Dementia or Mild Cognitive Impairment&#xD;
&#xD;
          -  MMSE less than 15&#xD;
&#xD;
          -  Physical or medical conditions that preclude participants from completing tasks&#xD;
&#xD;
          -  Healthy comparison volunteers if they have a known neurologic or psychiatric condition&#xD;
             that could impair neurocognitive functioning&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Barton W. Palmer, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UCSD</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Veterans Affairs San Diego Healthcare System</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92161</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Kim SY, Caine ED, Currier GW, Leibovici A, Ryan JM. Assessing the competence of persons with Alzheimer's disease in providing informed consent for participation in research. Am J Psychiatry. 2001 May;158(5):712-7.</citation>
    <PMID>11329391</PMID>
  </reference>
  <reference>
    <citation>Alzheimer's Association. Research consent for cognitively impaired adults: recommendations for institutional review boards and investigators. Alzheimer Dis Assoc Disord. 2004 Jul-Sep;18(3):171-5.</citation>
    <PMID>15494623</PMID>
  </reference>
  <reference>
    <citation>Kolata G. Alzheimer's research poses dilemma. Science. 1982 Jan 1;215(4528):47-8.</citation>
    <PMID>7053558</PMID>
  </reference>
  <reference>
    <citation>Dunn LB, Jeste DV. Enhancing informed consent for research and treatment. Neuropsychopharmacology. 2001 Jun;24(6):595-607.</citation>
    <PMID>11331139</PMID>
  </reference>
  <results_reference>
    <citation>Palmer BW, Harmell AL, Pinto LL, Dunn LB, Kim SY, Golshan S, Jeste DV. Determinants of Capacity to Consent to Research on Alzheimer's disease. Clin Gerontol. 2017;40(1):24-34. doi: 10.1080/07317115.2016.1197352. Epub 2016 Jun 7.</citation>
    <PMID>28154452</PMID>
  </results_reference>
  <verification_date>October 2016</verification_date>
  <study_first_submitted>March 28, 2007</study_first_submitted>
  <study_first_submitted_qc>March 28, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 29, 2007</study_first_posted>
  <last_update_submitted>October 26, 2016</last_update_submitted>
  <last_update_submitted_qc>October 26, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 28, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of California, San Diego</investigator_affiliation>
    <investigator_full_name>Barton W. Palmer, Ph.D.</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>computer assisted instruction</keyword>
  <keyword>decision making</keyword>
  <keyword>educational resource design /development</keyword>
  <keyword>executive function</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alzheimer Disease</mesh_term>
  </condition_browse>
  <pending_results>
    <submitted>September 24, 2019</submitted>
    <returned>October 14, 2019</returned>
    <submitted>August 5, 2022</submitted>
    <returned>August 26, 2022</returned>
    <submitted>November 4, 2022</submitted>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

